LGALS9 and Sepsis: We, as others (51), found significantly higher levels of Gal-9 in patients with severe disease (ranging from 5.4 ng/mL to 59.7 ng/mL) compared to mild/moderate cases (ranging from 4.1 ng/mL to 23.4 ng/mL) with the highest values observed in the non-survivors’ subgroup (ranging from 19.0 ng/mL to 59.7 ng/mL) and positive association with pro-inflammatory/sepsis biomarkers (sTREM-1, MCP-1, IL-6, NLR, PLR, VSH) and with neutrophils and eosinophils numbers.